87 related articles for article (PubMed ID: 30711998)
1. Serum CA 19.9 Levels in Patients With Benign and Malignant Disease: Correlation With the Serum Protein Electrophoretic Pattern.
Gundín-Menéndez S; Santos VM; Parra-Robert M; Pla XF; Fradera JMA; Porto RM
Anticancer Res; 2019 Feb; 39(2):1079-1083. PubMed ID: 30711998
[TBL] [Abstract][Full Text] [Related]
2. [Clinical value of the CA 19-9 tumor marker with special reference to the Lewis phenotype].
Kolb G; Safi F; Beckh K; Beger HG
Med Klin (Munich); 1997 Apr; 92(4):228-32. PubMed ID: 9221306
[TBL] [Abstract][Full Text] [Related]
3. Clinical performance of LOCI™-based tumor marker assays for tumor markers CA 15-3, CA 125, CEA, CA 19-9 and AFP in gynecological cancers.
Dolscheid-Pommerich RC; Keyver-Paik M; Hecking T; Kuhn W; Hartmann G; Stoffel-Wagner B; Holdenrieder S
Tumour Biol; 2017 Oct; 39(10):1010428317730246. PubMed ID: 29034816
[TBL] [Abstract][Full Text] [Related]
4. Relationship Between CA 19.9 and the Lewis Phenotype: Options to Improve Diagnostic Efficiency.
Parra-Robert M; Santos VM; Canis SM; Pla XF; Fradera JMA; Porto RM
Anticancer Res; 2018 Oct; 38(10):5883-5888. PubMed ID: 30275214
[TBL] [Abstract][Full Text] [Related]
5. Increased CA 19-9 level in patients without malignant disease.
Kim HR; Lee CH; Kim YW; Han SK; Shim YS; Yim JJ
Clin Chem Lab Med; 2009; 47(6):750-4. PubMed ID: 19402792
[TBL] [Abstract][Full Text] [Related]
6. Roles of serum and biliary CEA, CA19-9, VEGFR3, and TAC in differentiating between malignant and benign biliary obstructions.
Ince AT; Yıldız K; Baysal B; Danalıoğlu A; Kocaman O; Tozlu M; Gangarapu V; Sarbay Kemik A; Uysal Ö; Şentürk H
Turk J Gastroenterol; 2014 Apr; 25(2):162-9. PubMed ID: 25003676
[TBL] [Abstract][Full Text] [Related]
7. Serum Carbohydrate Antigen 19-9 in Differential Diagnosis of Benign and Malignant Pancreatic Cystic Neoplasms: A Meta-Analysis.
Cao S; Hu Y; Gao X; Liao Q; Zhao Y
PLoS One; 2016; 11(11):e0166406. PubMed ID: 27835676
[TBL] [Abstract][Full Text] [Related]
8. Etiologies of remarkably elevated serum levels of carbohydrate antigen 19-9.
Zhang H; Jia L; Xu Y
J BUON; 2021; 26(4):1653-1658. PubMed ID: 34565032
[TBL] [Abstract][Full Text] [Related]
9. Study of an elevated carbohydrate antigen 19-9 concentration in a large health check-up cohort in China.
Tong Y; Song Z; Zhu W
Clin Chem Lab Med; 2013 Jul; 51(7):1459-66. PubMed ID: 23492572
[TBL] [Abstract][Full Text] [Related]
10. Elevated level of serum carbohydrate antigen 19.9 as predictor of mortality in patients with advanced medullary thyroid cancer.
Elisei R; Lorusso L; Piaggi P; Torregrossa L; Pellegrini G; Molinaro E; Agate L; Bottici V; Pani F; Cacciato Insilla A; Casella F; Ciampi R; Tognetti I; Materazzi G; Basolo F; Romei C
Eur J Endocrinol; 2015 Sep; 173(3):297-304. PubMed ID: 26034076
[TBL] [Abstract][Full Text] [Related]
11. Copeptin is associated with the severity of endometriosis.
Tuten A; Kucur M; Imamoglu M; Kaya B; Acikgoz AS; Yilmaz N; Ozturk Z; Oncul M
Arch Gynecol Obstet; 2014 Jul; 290(1):75-82. PubMed ID: 24488583
[TBL] [Abstract][Full Text] [Related]
12. Effect of percutaneous biliary drainage on serum levels of tumor markers in patients with obstructive jaundice.
Koroglu M; Koroglu BK; Akhan O; Coskun HS; Yildizz H; Yesildag A; Oyar O
Hepatogastroenterology; 2006; 53(70):491-6. PubMed ID: 16995447
[TBL] [Abstract][Full Text] [Related]
13. Is CA242 really a new tumour marker for pancreatic adenocarcinoma?
Plebani M; Basso D; Navaglia F; D'Angeli F; Panozzo MP; Del Giudice G; Battistel M; Meggiato T; Del Favero G
Oncology; 1995; 52(1):19-23. PubMed ID: 7800337
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic value of carcinoembryonic antigen and carcinoma antigen 19-9 for colorectal carcinoma.
Zhang SY; Lin M; Zhang HB
Int J Clin Exp Pathol; 2015; 8(8):9404-9. PubMed ID: 26464695
[TBL] [Abstract][Full Text] [Related]
15. Studies on angiogenesis in the benign and malignant ovarian neoplasms with the use of color and pulsed Doppler sonography and serum CA-125, CA-19.9, CA-72.4 and vascular endothelial growth factor measurements.
Czekierdowski A
Ann Univ Mariae Curie Sklodowska Med; 2002; 57(1):113-31. PubMed ID: 12898913
[TBL] [Abstract][Full Text] [Related]
16. Gallbladder mass with a carbohydrate antigen 19-9 level in the thousands: malignant or benign pathology? Report of a case.
Clarke T; Matsuoka L; Jabbour N; Mateo R; Genyk Y; Selby R; Gagandeep S
Surg Today; 2007; 37(4):342-4. PubMed ID: 17387571
[TBL] [Abstract][Full Text] [Related]
17. Effect of obesity-related plasma hemodilution on serum tumor marker concentration in women.
Park M; Chang IH; Kang H; Han SS
J Obstet Gynaecol Res; 2015 May; 41(5):784-9. PubMed ID: 25421332
[TBL] [Abstract][Full Text] [Related]
18. The characteristics of the serum carcinoembryonic antigen and carbohydrate antigen 19-9 levels in gastric cancer cases.
Wada N; Kurokawa Y; Miyazaki Y; Makino T; Takahashi T; Yamasaki M; Nakajima K; Takiguchi S; Mori M; Doki Y
Surg Today; 2017 Feb; 47(2):227-232. PubMed ID: 27566604
[TBL] [Abstract][Full Text] [Related]
19. Serum CA 242: the search for a valid marker of pancreatic cancer.
Ventrucci M; Ubalducci GM; Cipolla A; Panella MA; Ligabue A
Clin Chem Lab Med; 1998 Mar; 36(3):179-84. PubMed ID: 9589807
[TBL] [Abstract][Full Text] [Related]
20. Precystectomy serum levels of carbohydrate antigen 19-9, carbohydrate antigen 125, and carcinoembryonic antigen: prognostic value in invasive urothelial carcinoma of the bladder.
Ahmadi H; Djaladat H; Cai J; Miranda G; Daneshmand S
Urol Oncol; 2014 Jul; 32(5):648-56. PubMed ID: 24680660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
